Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonis C Antoniou

Showing results (51-60 of 319) with videos related to

Pageof 32
Sort By:
Journal of Medical Genetics|May 31, 2015
A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effectsSarah Jervis, Honglin Song, Andrew Lee, et al.
Breast Cancer Research and Treatment|November 19, 2009
Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriersAmanda B Spurdle, Paul Fahey, Xiaoqing Chen, et al.
Journal of Community Genetics|October 25, 2024
Correction: Improving the communication of multifactorial cancer risk assessment results for different audiences: a co-design processFrancisca Stutzin Donoso, Tim Carver, Lorenzo Ficorella, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 9, 2024
Breast cancer risk assessment for prescription of menopausal hormone therapy in women with a family history of breast cancer: an epidemiological modelling studyCatherine Huntley, Bethany Torr, Grace Kavanaugh, et al.
Journal of Community Genetics|September 25, 2024
Improving the communication of multifactorial cancer risk assessment results for different audiences: a co-design processFrancisca Stutzin Donoso, Tim Carver, Lorenzo Ficorella, et al.
Breast (Edinburgh, Scotland)|February 27, 2026
Risk Stratified Breast Cancer Screening: Early Outcomes and Psychological Impact from PRSONAL - a Randomized Clinical TrialLine Hjøllund Pedersen, Janne Bigaard, Ilse Vejborg, et al.
American Journal of Obstetrics and Gynecology|July 11, 2017
Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestryRanjit Manchanda, Shreeya Patel, Antonis C Antoniou, et al.
JCO Precision Oncology|February 6, 2026
Modeling Individual-Level Uncertainty From Missing Data in Multifactorial Breast Cancer Risk PredictionBethan L White, Lorenzo Ficorella, Xin Yang, et al.
British Journal of Cancer|September 18, 2024
Validation of the BOADICEA model for epithelial tubo-ovarian cancer risk prediction in UK BiobankXin Yang, Yujia Wu, Lorenzo Ficorella, et al.
British Journal of Cancer|June 4, 2024
Joint ABS-UKCGG-CanGene-CanVar consensus regarding the use of CanRisk in clinical practiceOlga Tsoulaki, Marc Tischkowitz, Antonis C Antoniou, et al.
Pageof 32

Showing results (51-60 of 319) with videos related to

Sort By:
Pageof 32
Journal of Medical Genetics|May 31, 2015
A risk prediction algorithm for ovarian cancer incorporating BRCA1, BRCA2, common alleles and other familial effectsSarah Jervis, Honglin Song, Andrew Lee, et al.
Breast Cancer Research and Treatment|November 19, 2009
Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriersAmanda B Spurdle, Paul Fahey, Xiaoqing Chen, et al.
Journal of Community Genetics|October 25, 2024
Correction: Improving the communication of multifactorial cancer risk assessment results for different audiences: a co-design processFrancisca Stutzin Donoso, Tim Carver, Lorenzo Ficorella, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|May 9, 2024
Breast cancer risk assessment for prescription of menopausal hormone therapy in women with a family history of breast cancer: an epidemiological modelling studyCatherine Huntley, Bethany Torr, Grace Kavanaugh, et al.
Journal of Community Genetics|September 25, 2024
Improving the communication of multifactorial cancer risk assessment results for different audiences: a co-design processFrancisca Stutzin Donoso, Tim Carver, Lorenzo Ficorella, et al.
Breast (Edinburgh, Scotland)|February 27, 2026
Risk Stratified Breast Cancer Screening: Early Outcomes and Psychological Impact from PRSONAL - a Randomized Clinical TrialLine Hjøllund Pedersen, Janne Bigaard, Ilse Vejborg, et al.
American Journal of Obstetrics and Gynecology|July 11, 2017
Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestryRanjit Manchanda, Shreeya Patel, Antonis C Antoniou, et al.
JCO Precision Oncology|February 6, 2026
Modeling Individual-Level Uncertainty From Missing Data in Multifactorial Breast Cancer Risk PredictionBethan L White, Lorenzo Ficorella, Xin Yang, et al.
British Journal of Cancer|September 18, 2024
Validation of the BOADICEA model for epithelial tubo-ovarian cancer risk prediction in UK BiobankXin Yang, Yujia Wu, Lorenzo Ficorella, et al.
British Journal of Cancer|June 4, 2024
Joint ABS-UKCGG-CanGene-CanVar consensus regarding the use of CanRisk in clinical practiceOlga Tsoulaki, Marc Tischkowitz, Antonis C Antoniou, et al.
Pageof 32